What this means
Researchers plan to study Alzheimer's disease in older adults in South China. They will test thinking skills, blood, genes, and brain scans. This study has not reported any results yet, so it cannot yet tell us what they found.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 55–90
- Where
- 1 site
The science
- Registered title
- Greater-Bay-Area Healthy Aging Brain Study (GHABS)
- Trial ID
- NCT06183658 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Alzheimer's Disease
- What is tested
- Fluids biomarker and neuroimaging of AD diagnosis
- Sponsor
- Shenzhen Bay Laboratory
- Ages
- 55 Years to 90 Years
- Dates
- First posted Dec 27, 2023 · updated May 14, 2025
Registry summary
The goal of this observational study is to learn about the pathophysiology characterization and evolutionary patterns of Alzheimer's disease (AD) in South China older adults. The primary purposes are as follows:
- The prevalence and characteristics of AD in South China's aging population
- Identify novel biomarkers and neuroimaging techniques for early detection and intervention of AD
- Supporting and fertilizing novel approaches and techniques for early diagnosis and intervention of AD Participants will undergo cognitive assessments, blood sample collection, and genetic testing. Some will undergo CSF collection, stool sample collection, MRI scanning, Aβ PET scanning, and tau PET scanning.
Sites (1)
- Shenzhen Bay Laboratory, Shenzhen, Other, China